A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. - Ferrarotto, R; Eckhardt, G; Patnaik, A; LoRusso, P; Faoro, L; Heymach, J V; Kapoun, A M; Xu, L; Munster, P (Annals of Oncology, 2018)